Recent News

• 12.04.2025 - Medtronic announces cash dividend for third quarter of fiscal year 2026
• 12.03.2025 - Medtronic announces FDA clearance of Hugo™ robotic-assisted surgery system for urologic surgical procedures
• 12.02.2025 - Medtronic begins U.S. commercial launch of the MiniMed™ 780G system with the Instinct sensor, made by Abbott
• 11.18.2025 - Medtronic reports strong second quarter fiscal 2026 financial results, enterprise growth drivers accelerate momentum
• 11.05.2025 - Medtronic to announce financial results for its second quarter of fiscal year 2026
• 10.28.2025 - U.S. Centers for Medicare & Medicaid Services finalizes National Coverage Determination for the Medtronic Symplicity Spyral™ renal denervation (RDN) system
• 10.26.2025 - Three-year SPYRAL HTN-ON MED results show sustained, 18 mmHg office-based blood pressure reductions

Recent Filings

• 12.03.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 11.25.2025 - IRANNOTICE Notice of disclosure filed pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 (Exchange Act Section 13(r)).
• 11.25.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 11.24.2025 - 4 Statement of changes in beneficial ownership of securities
• 11.21.2025 - 4 Statement of changes in beneficial ownership of securities
• 11.19.2025 - 144 Report of proposed sale of securities
• 11.18.2025 - 8-K Current report
• 11.18.2025 - EX-99.1 EX-99.1
• 11.03.2025 - 8-K Current report
• 10.24.2025 - 11-K/A Annual report of employee stock purchase, savings and similar plans